Biotech Start-Up Democratizes CRISPR with Free-Access to Enzyme
Biotech Start-Up Democratizes CRISPR with Free-Access to Enzyme
Biotech Start-Up Democratizes CRISPR with Free-Access to Enzyme
A biotech firm based in Boulder, CO is providing free access to MAD7 a novel enzyme in the gene editing field.
Biotech Start-Up Democratizes CRISPR with Free-Access to Enzyme
20% of Young Colon Cancer Patients Have Inherited Genetic Abnormality
20% of Young Colon Cancer Patients Have Inherited Genetic Abnormality
20% of Young Colon Cancer Patients Have Inherited Genetic Abnormality
A new study indicates a benefit for all young colon cancer patients to have genetic testing.
20% of Young Colon Cancer Patients Have Inherited Genetic Abnormality
Light-Up Specks Find and Track Tiny Tumours
Light-Up Specks Find and Track Tiny Tumours
Light-Up Specks Find and Track Tiny Tumours
Scientists have created a method to detect tiny tumors and track their spread using light-emitting nanoparticles.
Light-Up Specks Find and Track Tiny Tumours
Thermo Fisher Scientific Launches New Research Assay for Cancer
Thermo Fisher Scientific Launches New Research Assay for Cancer
Thermo Fisher Scientific Launches New Research Assay for Cancer
Thermo Fisher Scientific has launched a new targeted next-generation sequencing research panel for the analysis of cancer-relevant genes.
Thermo Fisher Scientific Launches New Research Assay for Cancer
Sanofi is One Step Closer to Challenging Blockbuster Diabetes Sales from its Rival
Sanofi is One Step Closer to Challenging Blockbuster Diabetes Sales from its Rival
Sanofi is One Step Closer to Challenging Blockbuster Diabetes Sales from its Rival
Sanofi's Admelog is the first meal-time insulin copy the FDA has approved.
Sanofi is One Step Closer to Challenging Blockbuster Diabetes Sales from its Rival

Latest News

Webinars & Media

The Short Read

Magazines and Educational Guides

Educate Yourself

Complete Guide: Building a DNA Library

Just as sequencing has been getting faster, so too has library preparation. The process can be broadly broken up into 5-6 main stages, depending on method.

Saving Lives in Real Time

Does genomics have the power to revolutionise infectious disease control? We have brought together a panel of experts to answer just that.

Opinions

Exomes Are a Transition Test

We’ve caught up with Haim Neerman, CEO of Variantyx, to find out why the clinic is making the move to whole genome sequencing.

Around the Web

FLG Blog

5 Things to Read Instead Of…

Warming up for the weekend, we have a review of gene therapy, the lab of the future, and schools paving the way for big data analytics. 

5 Stories to Read Instead Of…

The most studied genes of all time; iPhone ultrasounds; migration of top life science talent; and still no science advisor at the White House…

5 Things to Read Instead Of…

Artifical embryos, databases offering clues on who likes beer, self-destruct switches in mosquitos and infectious disease…